These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 36875381)
1. A systematic review of barriers and facilitators for hepatitis B and C screening among migrants in the EU/EEA region. Moonen CPB; den Heijer CDJ; Dukers-Muijrers NHTM; van Dreumel R; Steins SCJ; Hoebe CJPA Front Public Health; 2023; 11():1118227. PubMed ID: 36875381 [TBL] [Abstract][Full Text] [Related]
2. How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review. Seedat F; Hargreaves S; Nellums LB; Ouyang J; Brown M; Friedland JS Lancet Infect Dis; 2018 Sep; 18(9):e259-e271. PubMed ID: 29778396 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries. Falla AM; Ahmad AA; Duffell E; Noori T; Veldhuijzen IK BMC Infect Dis; 2018 Jan; 18(1):42. PubMed ID: 29338702 [TBL] [Abstract][Full Text] [Related]
5. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia. Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144 [TBL] [Abstract][Full Text] [Related]
6. The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review. Myran DT; Morton R; Biggs BA; Veldhuijzen I; Castelli F; Tran A; Staub LP; Agbata E; Rahman P; Pareek M; Noori T; Pottie K Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30200406 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review. Mason LMK; Veldhuijzen IK; Duffell E; van Ahee A; Bunge EM; Amato-Gauci AJ; Tavoschi L J Viral Hepat; 2019 Dec; 26(12):1431-1453. PubMed ID: 31332919 [TBL] [Abstract][Full Text] [Related]
8. The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review. Greenaway C; Makarenko I; Chakra CNA; Alabdulkarim B; Christensen R; Palayew A; Tran A; Staub L; Pareek M; Meerpohl JJ; Noori T; Veldhuijzen I; Pottie K; Castelli F; Morton RL Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30223539 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with cervical cancer screening participation among migrant women in Europe: a scoping review. Marques P; Nunes M; Antunes MDL; Heleno B; Dias S Int J Equity Health; 2020 Sep; 19(1):160. PubMed ID: 32917224 [TBL] [Abstract][Full Text] [Related]
10. Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review. Bivegete S; McNaughton AL; Trickey A; Thornton Z; Scanlan B; Lim AG; Nerlander L; Fraser H; Walker JG; Hickman M; Vickerman P; Johnson H; Duffell E; Brooks-Pollock E; Christensen H Euro Surveill; 2023 Jul; 28(30):. PubMed ID: 37498533 [TBL] [Abstract][Full Text] [Related]
11. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review. Hofstraat SHI; Falla AM; Duffell EF; Hahné SJM; Amato-Gauci AJ; Veldhuijzen IK; Tavoschi L Epidemiol Infect; 2017 Oct; 145(14):2873-2885. PubMed ID: 28891457 [TBL] [Abstract][Full Text] [Related]
12. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups. Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454 [TBL] [Abstract][Full Text] [Related]
14. The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review. Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; Noori T; van der Werf MJ; Pottie K; Matteelli A; Zenner D; Morton RL Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637888 [TBL] [Abstract][Full Text] [Related]
15. Healthcare-associated hepatitis B and C transmission to patients in the EU/EEA and UK: a systematic review of reported outbreaks between 2006 and 2021. Singh J; Stoitsova S; Zakrzewska K; Henszel L; Rosińska M; Duffell E BMC Public Health; 2022 Dec; 22(1):2260. PubMed ID: 36463162 [TBL] [Abstract][Full Text] [Related]
16. Interventions to Improve Vaccination Uptake and Cost Effectiveness of Vaccination Strategies in Newly Arrived Migrants in the EU/EEA: A Systematic Review. Hui C; Dunn J; Morton R; Staub LP; Tran A; Hargreaves S; Greenaway C; Biggs BA; Christensen R; Pottie K Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30241320 [TBL] [Abstract][Full Text] [Related]
17. Barriers and facilitators to access mental health services among refugee women in high-income countries: a systematic review. DeSa S; Gebremeskel AT; Omonaiye O; Yaya S Syst Rev; 2022 Apr; 11(1):62. PubMed ID: 35387680 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review. Mason LM; Duffell E; Veldhuijzen IK; Petriti U; Bunge EM; Tavoschi L Euro Surveill; 2019 Jul; 24(30):. PubMed ID: 31362808 [TBL] [Abstract][Full Text] [Related]
19. The Effectiveness and Cost-Effectiveness of Screening for HIV in Migrants in the EU/EEA: A Systematic Review. Pottie K; Lotfi T; Kilzar L; Howeiss P; Rizk N; Akl EA; Dias S; Biggs BA; Christensen R; Rahman P; Magwood O; Tran A; Rowbotham N; Pharris A; Noori T; Pareek M; Morton R Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30096905 [TBL] [Abstract][Full Text] [Related]
20. Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA. Deblonde J; Sasse A; Del Amo J; Burns F; Delpech V; Cowan S; Levoy M; Keith L; Pharris A; Amato-Gauci A; Noori T BMC Public Health; 2015 Dec; 15():1228. PubMed ID: 26654427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]